Annexon Inc (ANNX)
7.255
+0.16
(+2.33%)
USD |
NASDAQ |
Nov 05, 16:00
7.255
0.00 (0.00%)
After-Hours: 18:39
Annexon Shareholders Equity (Quarterly): 361.08M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 361.08M |
| March 31, 2024 | 262.40M |
| December 31, 2023 | 250.56M |
| September 30, 2023 | 156.84M |
| June 30, 2023 | 184.72M |
| March 31, 2023 | 214.86M |
| December 31, 2022 | 231.19M |
| September 30, 2022 | 260.60M |
| June 30, 2022 | 168.04M |
| March 31, 2022 | 200.61M |
| Date | Value |
|---|---|
| December 31, 2021 | 231.91M |
| September 30, 2021 | 264.48M |
| June 30, 2021 | 295.34M |
| March 31, 2021 | 321.48M |
| December 31, 2020 | 344.28M |
| September 30, 2020 | 365.48M |
| June 30, 2020 | 117.18M |
| March 31, 2020 | 31.84M |
| December 31, 2019 | 43.53M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
31.84M
Minimum
Mar 2020
365.48M
Maximum
Sep 2020
226.65M
Average
231.91M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Arbutus Biopharma Corp | 122.45M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 406.08M |
| Total Liabilities (Quarterly) | 45.01M |